Agios Pharmaceuticals IncNASDAQ:AGIO
- LAST PRICE42.4500
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots40.9900/ 1
- Ask / Lots43.8700/ 1
- Open / Previous Close42.5000 / 42.4500
- Day Range
- 52 Week Range
- Volume570,007
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | AGIO |
|---|---|---|
| 09:32 ET | 5843 | 42.14 |
| 09:36 ET | 600 | 41.87 |
| 09:39 ET | 2102 | 41.92 |
| 09:41 ET | 1435 | 41.8686 |
| 09:43 ET | 1500 | 42.15 |
| 09:45 ET | 240 | 42.24 |
| 09:50 ET | 342 | 42.2 |
| 09:56 ET | 1750 | 42.17 |
| 09:57 ET | 800 | 42.22 |
| 09:59 ET | 1416 | 42.035 |
| 10:01 ET | 1600 | 42.36 |
| 10:03 ET | 100 | 42.275 |
| 10:06 ET | 1211 | 42.44 |
| 10:08 ET | 2400 | 42.37 |
| 10:12 ET | 300 | 42.37 |
| 10:14 ET | 719 | 42.48 |
| 10:15 ET | 1300 | 42.48 |
| 10:17 ET | 1500 | 42.235 |
| 10:24 ET | 800 | 42.2 |
| 10:26 ET | 544 | 42.12 |
| 10:28 ET | 700 | 42.26 |
| 10:30 ET | 1178 | 42.195 |
| 10:32 ET | 638 | 42.194 |
| 10:33 ET | 500 | 42.12 |
| 10:35 ET | 100 | 42.145 |
| 10:37 ET | 1400 | 42.1475 |
| 10:39 ET | 875 | 42.065 |
| 10:42 ET | 200 | 42 |
| 10:44 ET | 300 | 41.93 |
| 10:46 ET | 1151 | 41.98 |
| 10:50 ET | 200 | 41.96 |
| 10:51 ET | 7594 | 42.33 |
| 10:53 ET | 2000 | 42.255 |
| 10:55 ET | 400 | 42.21 |
| 10:57 ET | 1900 | 42.23 |
| 11:02 ET | 204 | 42.22 |
| 11:04 ET | 200 | 42.31 |
| 11:06 ET | 208 | 42.27 |
| 11:08 ET | 317 | 42.2432 |
| 11:09 ET | 2097 | 42.235 |
| 11:11 ET | 2861 | 42.19 |
| 11:15 ET | 300 | 42.245 |
| 11:18 ET | 1268 | 42.315 |
| 11:20 ET | 1103 | 42.39 |
| 11:22 ET | 704 | 42.425 |
| 11:24 ET | 1200 | 42.375 |
| 11:26 ET | 400 | 42.51 |
| 11:27 ET | 1482 | 42.5233 |
| 11:29 ET | 1000 | 42.43 |
| 11:31 ET | 600 | 42.33 |
| 11:33 ET | 200 | 42.33 |
| 11:36 ET | 700 | 42.23 |
| 11:38 ET | 100 | 42.22 |
| 11:40 ET | 400 | 42.04 |
| 11:42 ET | 3100 | 42.145 |
| 11:44 ET | 148 | 42.19 |
| 11:45 ET | 1000 | 42.095 |
| 11:47 ET | 100 | 42.185 |
| 11:49 ET | 400 | 42.07 |
| 11:51 ET | 300 | 42.06 |
| 11:56 ET | 3027 | 42.12 |
| 11:58 ET | 600 | 42.06 |
| 12:00 ET | 300 | 42.03 |
| 12:02 ET | 300 | 42.02 |
| 12:05 ET | 400 | 42.01 |
| 12:07 ET | 397 | 42.029 |
| 12:09 ET | 400 | 42.01 |
| 12:12 ET | 2950 | 42.11 |
| 12:14 ET | 904 | 42.21 |
| 12:16 ET | 1340 | 42.24 |
| 12:18 ET | 600 | 42.19 |
| 12:21 ET | 200 | 42.18 |
| 12:23 ET | 300 | 42.24 |
| 12:25 ET | 600 | 42.18 |
| 12:27 ET | 800 | 42.15 |
| 12:30 ET | 1100 | 42.16 |
| 12:32 ET | 1100 | 42.2 |
| 12:34 ET | 3535 | 42.11 |
| 12:36 ET | 200 | 42.06 |
| 12:39 ET | 400 | 42.13 |
| 12:41 ET | 1588 | 42.095 |
| 12:43 ET | 1700 | 42.04 |
| 12:45 ET | 700 | 42 |
| 12:48 ET | 1800 | 42.13 |
| 12:50 ET | 1100 | 42.08 |
| 12:54 ET | 666 | 42.105 |
| 12:56 ET | 200 | 42.15 |
| 12:57 ET | 700 | 42.07 |
| 12:59 ET | 2000 | 41.99 |
| 01:01 ET | 300 | 41.98 |
| 01:03 ET | 2076 | 42.08 |
| 01:06 ET | 1000 | 42.075 |
| 01:10 ET | 300 | 42.05 |
| 01:12 ET | 600 | 42.095 |
| 01:14 ET | 500 | 42.15 |
| 01:17 ET | 1200 | 42.13 |
| 01:19 ET | 400 | 42.195 |
| 01:21 ET | 400 | 42.12 |
| 01:24 ET | 400 | 42.17 |
| 01:26 ET | 400 | 42.21 |
| 01:28 ET | 1500 | 42.14 |
| 01:30 ET | 1000 | 42.12 |
| 01:32 ET | 400 | 42.1381 |
| 01:33 ET | 1800 | 42.08 |
| 01:35 ET | 600 | 42.06 |
| 01:37 ET | 2190 | 41.995 |
| 01:39 ET | 1926 | 41.97 |
| 01:42 ET | 200 | 41.97 |
| 01:44 ET | 1320 | 42.15 |
| 01:46 ET | 200 | 42.115 |
| 01:48 ET | 1300 | 42.07 |
| 01:50 ET | 700 | 42.115 |
| 01:51 ET | 100 | 42.13 |
| 01:53 ET | 300 | 42.15 |
| 01:55 ET | 1000 | 42.3 |
| 01:57 ET | 346 | 42.3 |
| 02:00 ET | 1240 | 42.28 |
| 02:02 ET | 400 | 42.27 |
| 02:04 ET | 100 | 42.315 |
| 02:06 ET | 400 | 42.34 |
| 02:08 ET | 600 | 42.34 |
| 02:09 ET | 1303 | 42.3186 |
| 02:11 ET | 800 | 42.385 |
| 02:13 ET | 1700 | 42.3 |
| 02:15 ET | 300 | 42.36 |
| 02:18 ET | 886 | 42.29 |
| 02:20 ET | 200 | 42.28 |
| 02:22 ET | 700 | 42.36 |
| 02:24 ET | 560 | 42.3687 |
| 02:27 ET | 700 | 42.34 |
| 02:29 ET | 2250 | 42.46 |
| 02:31 ET | 1406 | 42.37 |
| 02:33 ET | 500 | 42.41 |
| 02:36 ET | 2104 | 42.335 |
| 02:38 ET | 100 | 42.3 |
| 02:40 ET | 600 | 42.305 |
| 02:42 ET | 1600 | 42.335 |
| 02:44 ET | 400 | 42.365 |
| 02:45 ET | 1200 | 42.35 |
| 02:47 ET | 600 | 42.33 |
| 02:49 ET | 500 | 42.33 |
| 02:51 ET | 1354 | 42.33 |
| 02:54 ET | 1111 | 42.32 |
| 02:56 ET | 1100 | 42.37 |
| 02:58 ET | 900 | 42.34 |
| 03:00 ET | 1078 | 42.38 |
| 03:02 ET | 2890 | 42.31 |
| 03:03 ET | 954 | 42.2 |
| 03:05 ET | 555 | 42.05 |
| 03:07 ET | 300 | 42.14 |
| 03:09 ET | 1125 | 42.18 |
| 03:12 ET | 2700 | 42.33 |
| 03:14 ET | 1348 | 42.29 |
| 03:16 ET | 2950 | 42.29 |
| 03:18 ET | 700 | 42.255 |
| 03:20 ET | 2300 | 42.21 |
| 03:21 ET | 967 | 42.24 |
| 03:23 ET | 1500 | 42.185 |
| 03:25 ET | 333 | 42.22 |
| 03:27 ET | 900 | 42.25 |
| 03:30 ET | 700 | 42.18 |
| 03:32 ET | 2017 | 42.1 |
| 03:34 ET | 800 | 42.12 |
| 03:36 ET | 1600 | 42.09 |
| 03:38 ET | 1250 | 41.975 |
| 03:39 ET | 11264 | 42.16 |
| 03:41 ET | 3697 | 42.16 |
| 03:43 ET | 25607 | 42.11 |
| 03:45 ET | 600 | 42.23 |
| 03:48 ET | 3399 | 42.28 |
| 03:50 ET | 5660 | 42.23 |
| 03:52 ET | 6931 | 42.28 |
| 03:54 ET | 6291 | 42.39 |
| 03:56 ET | 14525 | 42.373 |
| 03:57 ET | 15978 | 42.38 |
| 03:59 ET | 121196 | 42.45 |
Jun 15, 2024
Agios Presents Positive Results from Phase 3 -2-, from 8:45AM ET on Saturday Jun 15, 2024 by Dow Jones
8:45AM ET on Saturday Jun 15, 2024 by Dow Jones
Jun 13, 2024
DJ Agios Pharmaceuticals Price Target Announced at $46.00/Share by JP Morgan, from 5:17PM ET on Thursday Jun 13, 2024 by Dow Jones
5:17PM ET on Thursday Jun 13, 2024 by Dow Jones
Jun 6, 2024
Updated Time: Agios to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024 at 8:40 am ET, from 9:00AM ET on Thursday Jun 06, 2024 by Dow Jones
9:00AM ET on Thursday Jun 06, 2024 by Dow Jones
Jun 4, 2024
DJ Agios Pharmaceuticals Is Maintained at Neutral by Goldman Sachs, from 11:26AM ET on Tuesday Jun 04, 2024 by Dow Jones
11:26AM ET on Tuesday Jun 04, 2024 by Dow JonesDJ Agios Pharmaceuticals Is Maintained at Outperform by RBC Capital, from 9:41AM ET on Tuesday Jun 04, 2024 by Dow Jones
9:41AM ET on Tuesday Jun 04, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Agios Pharmaceuticals Inc | 2.4B | -6.7x | --- |
Intellia Therapeutics Inc | 2.4B | -4.5x | --- |
Recursion Pharmaceuticals Inc | 2.3B | -5.7x | --- |
Celldex Therapeutics Inc | 2.3B | -12.5x | --- |
MoonLake Immunotherapeutics | 2.5B | -52.6x | --- |
CG Oncology Inc | 2.3B | -28.5x | --- |
Company Information
Agios Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on developing and delivering transformative therapies for patients living with rare diseases. It markets a first-in-class pyruvate kinase (PK) activator for adults with PK deficiency, the first disease-modifying therapy for debilitating hemolytic anemia. Its lead product candidate in its genetically defined disease (GDD) portfolio, PYRUKYND (Mitapivat), is an activator of both wild-type and a variety of mutant pyruvate kinase (PK) enzymes, for the treatment of hemolytic anemias. The Mitapivat is an orally available small molecule and a potent activator of the pyruvate kinase R (PKR) enzymes. In addition, it is also evaluating mitapivat for the treatment of alpha- and beta- thalassemia and sickle cell disease (SCD) in ongoing clinical trials. The Company is also developing AG-946, a clinical-stage oral activator of PKR enzymes for the treatment of hemolytic anemias and other indications, including SCD.
Contact Information
- Headquarters
- 88 Sidney StreetCAMBRIDGE, MA, United States 02139
- Phone
- 617-649-8600
- Fax
- 302-655-5049
Executives
- Chairman of the Board
- Jacqualyn Fouse
- Chief Executive Officer, Director
- Brian Goff
- Chief Financial Officer
- Cecilia Jones
- Chief Legal Officer
- James Burns
- Chief Medical Officer, Head - Research and Development
- Sarah Gheuens
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.4B |
|---|---|
Revenue (TTM) | $29.4M |
Shares Outstanding | 56.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.78 |
EPS | $-6.31 |
Book Value | $14.50 |
P/E Ratio | -6.7x |
Price/Sales (TTM) | 82.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -1,336.42% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
